Latest Articles

Publication Date
BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial - BioSpace

BioNTech, DualityBio tout 'clinically meaningful' efficacy for ADC in mid-stage endometrial cancer trial BioSpace

Published: April 13, 2026, 5:57 p.m.
Endometriosis: ‘I was vomiting green. It’s like cancer without being cancer.’ - Luxembourg Times

Endometriosis: ‘I was vomiting green. It’s like cancer without being cancer.’ Luxembourg Times

Published: April 13, 2026, 4 p.m.
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer - MedPage Today

Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer MedPage Today

Published: April 13, 2026, 3:43 p.m.
Fire destroys trailer, damages mobile home in Palmyra - newscentermaine.com

Fire destroys trailer, damages mobile home in Palmyra newscentermaine.com

Published: April 13, 2026, 1:39 p.m.
SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

SGO 2026 – GSK bucks the B7-H4 trend | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: April 13, 2026, 12:32 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks

BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks

Published: April 13, 2026, 12:29 p.m.
BBC Breakfast's Naga Munchetty left 'curled up on the floor screaming' after 'extreme pain' - Manchester Evening News

BBC Breakfast's Naga Munchetty left 'curled up on the floor screaming' after 'extreme pain' Manchester Evening News

Published: April 13, 2026, 12:22 p.m.
Maine braces for another tick season amid promising Lyme vaccine trials - newscentermaine.com

Maine braces for another tick season amid promising Lyme vaccine trials newscentermaine.com

Published: April 13, 2026, 12:16 p.m.
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com

Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com

Published: April 13, 2026, 12:14 p.m.
Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal - Stock Titan

Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal Stock Titan

Published: April 13, 2026, 11:55 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!